Better blood tests could cut transfusions for young heart patients
NCT ID NCT02410473
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at new ways to test blood clotting in 200 children with congenital heart disease undergoing surgery. The goal was to see if newer technologies like TEG, ROTEM, and T2MR could help doctors manage bleeding more precisely and reduce the need for blood transfusions. The research used leftover blood and urine samples to develop a better approach for treating bleeding and preventing clots after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL HEART DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart surgery in childhood: a hidden impact on speech and memory?
- A website designed to steer teens with heart defects away from vaping
- AI stethoscope aims to spot hidden heart and lung problems in children
- Can community hospitals in zambia master severe disease care?
- App-Based exercise program aims to strengthen hearts in congenital disease
- Which nerve block eases Children's heart surgery pain better?